arGentis Pharmaceuticals, LLS is a private TN based pharmaceutical company with a mid-stage Orphan Drug treatment (ARG201) for late stage diffuse systemic scleroderma (dcSSc). The company is seeking capital to complete a Pivotal Clinical Trial which will enable obtaining marketing approval in the EU.The Company has a genotype marker (ROT1) thatpredicts patient response to treatment by oral tolerance for treatments like ARG201 for dcSSc.

Pharmaceutical

arGentis Pharmaceuticals, LLC

arGentis Pharmaceuticals, LLC's headquarters in Collierville, TN, United States

Description

People

Jobs